BANGKOK (NNT) – AstraZeneca has approved safety standards at Thailand’s vaccine factory and will send the first batch of raw materials for vaccine production in June.

Public Health Minister Anutin Charnvirakul said an AstraZeneca representative had visited the Thai plant and was satisfied with the manufacturing standards. Siam Bioscience is upgrading its plant in Pathum Thani to produce millions of AstraZeneca doses for Thailand and neighboring countries in Southeast Asia.

Meanwhile, the Public Health Ministry will launch a project on Covid-19 vaccine efficiency among people who received the Sinovac or AstraZeneca vaccines to learn more about their ability to build up immunity in the body.

Results of the test project are expected to be known within the next two months and will help shape the government’s vaccine policy for the next 12 months.

Information and Source
Reporter : Paphamon Arayasukawat
Rewriter : Paphamon Arayasukawat
National News Bureau & Public Relations : http://thainews.prd.go.th

About the author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign Up for Our Newsletter

Get notified of our weekly selection of news

You May Also Like

Thailand Spent $12.6 Billion to Handle COVID-19 Pandemic

From 2020 to 2022, the government covered the cost of treatment and vaccinations for all citizens, with the majority of the funding coming from the annual budget.

Thai medical tourism market to recover to pre-Covid level in 2023

According to SCB EIC estimates, the Thai medical tourism market in 2023 is likely to recover to a higher level than in 2019 and will be valued at 2 billion baht.

SET welcomes pet food and treat manufacturer “ITC”

The company, which is ranked number two in Asia and among the top 10 pet food makers in the world in terms of revenue, has a market capitalization at its initial public offering (IPO) of THB 96 billion (approx. USD 2.74 billion)